|
Ventura bags major US partner for COPD/asthma combo copy
Pharma Times … division of an undisclosed leading international pharmaceutical company" for VR315, a combination therapy for chronic obstructive pulmonary disease and asthma that is widely thought to be a generic version of GlaxoSmithKline's blockbuster Advair. … Vectura Signs Up US Partner For VR315 Lung Drug Vectura signs US license agreement for VR315 product Vectura gets new US partner for copy of lung drug |
View full post on asthma – Google News